Request Discount

Drug Screening Laboratory Market (Sample Type - Urine Samples, Breath Samples, Oral Fluid Samples, Hair Samples, and Other; End User - Hospital Laboratories, Clinical Laboratories, and Other): Global Industry Analysis, Trends, Size, Share and Forecasts to 2026

  • Published : June, 2021

  • Rep Id : HC08683

  • Category : Healthcare & Medical Devices

  • Status : Published

A recent report published by Infinium Global Research on the drug screening laboratory market provides an in-depth analysis of segments and sub-segments in the global as well as regional drug screening laboratory market. The study also highlights the impact of drivers, restraints, and macro indicators on the global and regional drug screening laboratory market over the short term as well as long term. The report is a comprehensive presentation of trends, forecast, and dollar values of the global drug screening laboratory market. According to the report, the global drug screening laboratory market is projected to grow from USD 6.5 billion in 2020 to USD 11.8 Billion at a CAGR of 12% over the forecast period of 2020-2026.


Market Insight

Drug screening plays a key role in target identification and validation, and so the quality of the chosen screening technique can be a deciding factor in whether a new drug makes it into the laboratory. The drug discovery sector is being revolutionized by the current rate of advances in screening technologies. The demand for sophisticated prognostic, diagnostic, and monitoring tests will be increasing as the genetic roots of disease, disease progression, and treatment effectiveness are uncovered. This has led to the expansion of novel diagnostics products meeting the criteria of better efficacy and safety as well as better cost-benefits.


The growing influence of social media dissociates the young age people from society this is helping to grow the drug abuse testing and hence screening laboratory market. Furthermore, the increasingly stringent law mandating alcohol and drug testing and growing government initiatives driving the growing demand of the market. The growth of the urban population and increase in affluence and disposable income appear to be the principal causes of expanding drug usage over the world. In addition, the increasing government measures to control drug abuse will mandate alcohol and drug testing in the market. Additionally, the increasing availability of opioid drugs is boosting the growth of this market. However, the lack of awareness about the modern drug screening procedures, lack of skilled professionals, and an absence of drug abuse testing enforcement authority is likely to affect the growth of the market for the short term. Nevertheless, the growing technological advancements, less time-consuming testing, and increased sensitivity along with significant advances in terms of drug policies in the coming years will propel the growth of the market.


The outbreak of COVID-19 has disrupted workplace drug screening and background checks are no exceptions. The growth in drug misuse and substance abuse has been reported in the United States and other countries worldwide since the advent of the pandemic. Since state and municipal governments are also highly exposed to the crisis caused due to the pandemic, new investments in drug abuse testing are also likely to drop in the short term. Nevertheless, shifts to narcotics such as new synthetic opioids or designer benzodiazepines that are available online have been witnessed in the market. The drug abuse screening test market will therefore witness an increased demand for drug abuse testing in the coming years.


North America holds the largest share of the drug of abuse testing market owing to the increasing number of clinical laboratories that offer drug of abuse testing services in this region. Further, favorable government initiatives provide growing demand for a drug of abuse testing market in this region. The Asia Pacific anticipated observing a significant amount of growth in the drug screening market in the forecasted period. It is owing to the expansion in research and development services, accessible disposable income, and promptly creating economic circumstances in the region.


Drug Screening Laboratory Market

Segment Covered

The report on the global drug screening laboratory market covers segments such as sample type, and end user. On the basis of sample type, the sub-markets include urine samples, breath samples, oral fluid samples, hair samples, and other. On the basis of end user, the sub-markets include hospital laboratories, clinical laboratories, and other.


Companies Profiled:

The report provides profiles of the companies in the market such as Abbott Laboratories, Hoffmann-La Roche AG, Biorad Laboratories, Inc., Alere, Inc., Drägerwerk AG & Co. KGAA, Siemens AG, Thermo Fisher Scientific, Inc., Danaher Corporation, Express Diagnostics International Inc., and Quest Diagnostics Incorporated.


Report Highlights:

The report provides deep insights into the demand forecasts, market trends, and micro and macro indicators. In addition, this report provides insights into the factors that are driving and restraining the growth in this market. Moreover, The IGR-Growth Matrix analysis given in the report brings an insight into the investment areas that existing or new market players can consider. The report provides insights into the market using analytical tools such as Porter's five forces analysis and DRO analysis of drug screening laboratory market. Moreover, the study highlights current market trends and provides forecast from 2020-2026. We also have highlighted future trends in the market that will affect the demand during the forecast period. Moreover, the competitive analysis given in each regional market brings an insight into the market share of the leading players.

Other Reports in This Category
24 hour delivery through email
9923950043 Monday to Frieday 9am-7pm
looking for discount